Stimuli-Responsive Nanoparticles for Pharmaceutical Application in Cancer
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: closed (30 April 2023) | Viewed by 2836
Special Issue Editors
Interests: mesoporous silica nanoparticles; stimuli-responsive nanosystems; targeted drug delivery
Special Issues, Collections and Topics in MDPI journals
Interests: drug delivery; mesoporous silica nanoparticles; nanotheranostics; injectable hydrogels; triggered release
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Stimuli-responsive nanocarriers for the controlled release of encapsulated cargo represent a powerful tool to minimize the risk of systemic exposure of non-target tissues to drugs, thus avoiding undesired side effects and drug–plasma interactions, and to increase the site-specific concentration of a drug or of a signalling molecule. The ability of a nanosystem to modify its physicochemical properties in response to external stimuli or environmental conditions, producing a variation in its structure or function, perfectly illustrates the concept of nanostructures as defined by the EMA in the following terms: a system with specific properties that are not obtainable with its isolated individual components, and that confer clinical advantages.
This Special Issue’s goal is to highlight current progress in the development of anti-tumour therapeutic strategies based on stimuli-responsive nanocarriers. We invite review or original articles on all aspects of “Stimuli-Responsive Nanoparticles for Pharmaceutical Application in Cancer”.
Dr. Amelia Ultimo
Dr. Eduardo Ruiz-Hernandez
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanomedicine
- stimuli-responsive nanoparticles
- drug/gene delivery systems
- cancer therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.